NewGenIvf Group (NASDAQ:NIVF) Major Shareholder Financial Lp Hrt Acquires 27,993 Shares

NewGenIvf Group Limited (NASDAQ:NIVF) major shareholder Financial Lp Hrt acquired 27,993 shares of the stock in a transaction that occurred on Tuesday, May 26th. The stock was purchased at an average cost of $0.92 per share, with a total value of $25,753.56. Following the completion of the acquisition, the insider owned 139,878 shares of the company’s stock, valued at $128,687.76. The trade was a 25.02% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Friday, May 22nd, Financial Lp Hrt acquired 137,541 shares of NewGenIvf Group stock. The stock was purchased at an average cost of $0.99 per share, with a total value of $136,165.59.

NewGenIvf Group Price Performance

NIVF stock traded up $0.08 during midday trading on Wednesday, reaching $0.86. The company had a trading volume of 491,241 shares, compared to its average volume of 1,415,830. The company has a debt-to-equity ratio of 0.16, a quick ratio of 2.98 and a current ratio of 3.12. The stock has a 50 day moving average price of $1.71 and a 200 day moving average price of $7.16. NewGenIvf Group Limited has a fifty-two week low of $0.72 and a fifty-two week high of $1,839.00.

NewGenIvf Group (NASDAQ:NIVF) last issued its earnings results on Tuesday, March 31st. The company reported ($287.24) EPS for the quarter. The business had revenue of $1.42 million during the quarter. On average, equities analysts predict that NewGenIvf Group Limited will post 4.74 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of NewGenIvf Group in a report on Monday, April 27th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.